You are here

Study Finds Cangrelor Safe and Effective in Older Patients

Cardiologist Matt Cavender of Brigham and Women’s Hospital in Boston says that in a study of about 2,000 patients at least 75 years of age, those who received cangrelor prior to percutaneous coronary intervention fared better than those who received clopidogrel, mirroring results in younger patients.

American College of Cardiology, March 2015